214390.KS
Kyongbo Pharmaceutical Co., Ltd [214390.KS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
214390.KS Stock Summary
In the News
214390.KS Financial details
Company Rating
-
Market Cap
177.87B
Income
2.97B
Revenue
216.36B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
505
Optionable
No
Shortable
Yes
Earnings
29 Jan 2024
P/E
81.4
Forward P/E
-
PEG
2.1
P/S
0.9
P/B
1.35
P/C
-
P/FCF
-34.72
Quick Ratio
-
Current Ratio
1.13
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
124.41
EPS next Y
-
EPS next Q
-
EPS this Y
387.16%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-10.86%
Revenue last 5Y
2.45%
Revenue Q/Q
12.25%
EPS Q/Q
166.45%
-
-
-
-
SMA20
-2.52%
SMA50
-3.74%
SMA100
-24.86%
Inst Own
-
Inst Trans
-
ROA
1%
ROE
2%
ROC
0.04%
Gross Margin
28%
Oper. Margin
3%
Profit Margin
1%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
6060.0-10950.0
52W High
-55.48%
52W Low
-19.55%
RSI
27.83
Rel Volume
0.7
Avg Volume
98.42K
Volume
68.45K
Perf Week
-11.04%
Perf Month
-11.36%
Perf Quarter
-
Perf Half Y
-34.48%
-
-
-
-
Beta
1.144
-
-
Volatility
214.45%, 169.68%
Prev Close
-2.3%
Price
4875
Change
-2.69%
Company Profile
- Volume Average 98.42K
- Market Capitalization 177.87B
- Employee 505
- CEO Tae-Young Kim
- Headquarters Asan,KR
- IPO Date 2015-06-29
-
Website
https://www.kbpharma.co.kr 
Kyongbo Pharmaceutical Co., Ltd manufactures and sells active pharmaceutical ingredients in South Korea. The company offers general, cephalosporins, and anti-cancer APIs; prescription drugs, including anesthetic, cardiovascular, digestive, and antibiotics; and OTC drugs. It also exports its products to 30 countries worldwide. The company was formerly known as Kyongbo Chemical Co. Ltd. and changed its name to Kyongbo Pharmaceutical Co., Ltd in March 2002. Kyongbo Pharmaceutical Co., Ltd was founded in 1987 and is headquartered in Asan, South Korea.
